Resurfix Plus
Resurfix Plus is an FDA drug label for the active ingredient PETROLATUM manufactured by Topiderm, Inc. administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20191119.
- Generic name
- PETROLATUM
- Manufacturer
- Topiderm, Inc.
- Product type
- HUMAN OTC DRUG
- Route
- TOPICAL
- Dosage form
- N/A
- NDC
- 51326-884
- Application
- M016
- Label effective
- 20191119
Active ingredients
Indications & Usage
Uses A unique dressing formulated to aid in the Skin Barrier healing process. Also provides protection and helps heal stressed skin conditions such as chapped, dry and windburned skin.
Dosage & Administration
Directions Apply as directed by your physician.
Contraindications
Not available.
Warnings
Warnings Not to be applied over puncture wounds, infections, or lacerations. If condition worsens or does not improve within 7 days, contact a physician. Keep out of reach of children. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately. For external use only, not to be swallowed. Avoid contact with eyes.
Adverse Reactions
Not available.